Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cell and gene therapy investment: evolution and future outlook on investor perspectives

28 Feb 2024

Abstract excerpt

BACKGROUND AIMS: To better understand the attitudes and behaviors of investors involved in funding cell and gene therapy (CGT) businesses, the Business Development and Finance) subcommittee of International Society for Cell and Gene Therapy, in collaboration with Truist Securities, conducted a broad survey of the investment community in late 2021. METHODS: This survey follows a similar study that this group...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Ethics and Regulation
Share to Biotechnology and Related Fields
Share to CAR-T cell therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38483363
DOI: 10.1016/j.jcyt.2024.02.017

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cell and gene therapy investment: evolution and future outlook on investor perspectivesPMID 38483363Read ↗

The Past, Present, and (Near) Future of Gene Therapy and Gene EditingSemantic proximity Read ↗

Clinical development of gene- and cell-based therapies: overview of the European landscapeSemantic proximity Read ↗

Financing translation: Analysis of the NCATS rare-diseases portfolioSemantic proximity Read ↗

Regulatory insights on advanced CAR-T cell products, AAV-based Gene therapies, and medical care/practice in cell and Gene therapies: Report from the 6th Asia partnership conference of regenerative medicine- April 20, 2023Semantic proximity Read ↗

“A Process-Based Approach to Conflicts of Interest”Semantic proximity Read ↗

Patient, consumer and societal values, perceptions and preferences on high-cost gene therapiesSemantic proximity Read ↗

Estimating the Financial Impact of Gene Therapy*Semantic proximity Read ↗

The estimated annual financial impact of gene therapy in the United StatesSemantic proximity Read ↗

Comparison of Clinical Evidence Submitted to the FDA and EMA for Cell and Gene TherapiesSemantic proximity Read ↗

Considerations driving the choice in clinical trial design of cell and gene therapy products: weighing convenience versus necessitySemantic proximity Read ↗

The Amortization of Funding Gene Therapies: Making the “Intangibles” Tangible for PatientsSemantic proximity Read ↗

Scientific exploration outlasts industrial momentum and sustains innovation in genetic research: survey of 20 million papers and patentsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.